S Iodice

Summary

Affiliation: European Institute of Oncology
Country: Italy

Publications

  1. doi Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis
    S Iodice
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Eur J Cancer 46:2275-84. 2010
  2. doi ABO blood group and cancer
    Simona Iodice
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Eur J Cancer 46:3345-50. 2010
  3. doi Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysis
    S Iodice
    European Institute of Oncology, Milan, Italy
    J Thromb Haemost 6:781-8. 2008
  4. pmc Case mix at the European Institute of Oncology: first report of the Tumour Registry, 2000-2002
    E Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
    Ecancermedicalscience 3:149. 2009

Detail Information

Publications4

  1. doi Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis
    S Iodice
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Eur J Cancer 46:2275-84. 2010
    ..The association between oral contraceptive and BRCA1 or BRCA2 gene mutations carriers is unclear...
  2. doi ABO blood group and cancer
    Simona Iodice
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    Eur J Cancer 46:3345-50. 2010
    ..ABO blood type has been associated with various malignancies, including pancreatic cancer. Our aim was to study this association using data from a hospital-based tumour registry...
  3. doi Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysis
    S Iodice
    European Institute of Oncology, Milan, Italy
    J Thromb Haemost 6:781-8. 2008
    ..Despite a recognized association between venous thromboembolic events (VTE) and cancer, little is known about the strength and the features of this association. We performed a meta-analysis in order to clarify this issue...
  4. pmc Case mix at the European Institute of Oncology: first report of the Tumour Registry, 2000-2002
    E Botteri
    Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
    Ecancermedicalscience 3:149. 2009
    ..The purpose of this paper is to describe the development of the TR at the European Institute of Oncology (IEO), Milan, Italy, from its origin to its current applications...